193 related articles for article (PubMed ID: 16434174)
21. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
[TBL] [Abstract][Full Text] [Related]
22. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
Koopmans JG; Lutter R; Jansen HM; van der Zee JS
Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264
[TBL] [Abstract][Full Text] [Related]
23. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
Ferguson GT; Anzueto A; Fei R; Emmett A; Knobil K; Kalberg C
Respir Med; 2008 Aug; 102(8):1099-108. PubMed ID: 18614347
[TBL] [Abstract][Full Text] [Related]
24. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
[TBL] [Abstract][Full Text] [Related]
25. Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis.
Steinfort DP; Steinfort C
Intern Med J; 2007 Jul; 37(7):495-8. PubMed ID: 17547727
[TBL] [Abstract][Full Text] [Related]
26. Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients.
Adachi M; Aizawa H; Ishihara K; Ohta K; Sano Y; Taniguchi H; Nakashima M
Respir Med; 2008 Jul; 102(7):1055-64. PubMed ID: 18394875
[TBL] [Abstract][Full Text] [Related]
27. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough.
Chaudhuri R; McMahon AD; Thomson LJ; MacLeod KJ; McSharry CP; Livingston E; McKay A; Thomson NC
J Allergy Clin Immunol; 2004 Jun; 113(6):1063-70. PubMed ID: 15208586
[TBL] [Abstract][Full Text] [Related]
28. Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis.
Guran T; Ersu R; Karadag B; Karakoc F; Demirel GY; Hekim N; Dagli E
J Clin Pharm Ther; 2008 Dec; 33(6):603-11. PubMed ID: 19138237
[TBL] [Abstract][Full Text] [Related]
29. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis.
Tsang KW; Ho PL; Lam WK; Ip MS; Chan KN; Ho CS; Ooi CC; Yuen KY
Am J Respir Crit Care Med; 1998 Sep; 158(3):723-7. PubMed ID: 9730996
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
32. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.
Nicolson CH; Stirling RG; Borg BM; Button BM; Wilson JW; Holland AE
Respir Med; 2012 May; 106(5):661-7. PubMed ID: 22349069
[TBL] [Abstract][Full Text] [Related]
33. A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma.
Iles R; Williams RM; Deeb A; Ross-Russell R; Acerini CL
Pediatr Pulmonol; 2008 Apr; 43(4):354-9. PubMed ID: 18286548
[TBL] [Abstract][Full Text] [Related]
34. Inhaled corticosteroid for persistent cough following upper respiratory tract infection.
Pornsuriyasak P; Charoenpan P; Vongvivat K; Thakkinstian A
Respirology; 2005 Sep; 10(4):520-4. PubMed ID: 16135178
[TBL] [Abstract][Full Text] [Related]
35. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
[TBL] [Abstract][Full Text] [Related]
36. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children.
Volovitz B; Bilavsky E; Nussinovitch M
J Asthma; 2008 Sep; 45(7):561-7. PubMed ID: 18773327
[TBL] [Abstract][Full Text] [Related]
38. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
[TBL] [Abstract][Full Text] [Related]
39. [Inhalation of hypertonic saline: a promising therapy in bronchiectasis].
Koskela H; Purokivi M
Duodecim; 2011; 127(24):2653-9. PubMed ID: 22320108
[TBL] [Abstract][Full Text] [Related]
40. Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.
Paredes Aller S; Quittner AL; Salathe MA; Schmid A
Expert Rev Respir Med; 2018 Sep; 12(9):769-782. PubMed ID: 30025482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
